Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) has provided an announcement.
MedPlus Health Services has disclosed that its subsidiary, Optival Health Solutions Private Limited, received a seven-day suspension of a drug license for one pharmacy located on Bhimavaram P P Road in Andhra Pradesh. The suspension order was issued by the Assistant Director, Drugs Control Administration, Eluru and West Godavari District, under Rule 65 of the Drugs and Cosmetics Act, 1940 and related rules.
The company estimates a potential revenue loss of Rs 1.93 lakh from the temporary closure of this single store, indicating a limited financial impact at the consolidated level. MedPlus has made the regulatory update available on its website and through stock exchanges, signaling compliance with SEBI disclosure requirements and transparency toward investors and other stakeholders.
More about MedPlus Health Services Ltd.
MedPlus Health Services Limited operates in the healthcare and pharmaceutical retail sector, primarily through its MedPlus pharmacy chain and related health solutions. The company serves consumers across India with a focus on prescription medicines, over-the-counter drugs, and allied healthcare products, supported by subsidiaries such as Optival Health Solutions Private Limited.
Average Trading Volume: 17,108
Technical Sentiment Signal: Buy
Current Market Cap: 98.58B INR
For detailed information about MEDPLUS stock, go to TipRanks’ Stock Analysis page.